Lisata Therapeutics And Qilu Pharmaceutical Announce First Patient Treated In Qilu S Phase 2 Trial In China Of LSTA1 In Patients With Metastatic Pancr menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Lisata Therapeutics, Inc. and Qilu Pharmaceutical Co. Ltd. announced that the first patient has been treated in Qilu?s Phase 2 trial in China evaluating LSTA1 , Lisata?s lead product candidate, in.
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.